CT Contrast Medium for Detecting Thrombus, Comprising Fibrin-Targeted Peptide Sequence-Conjugated Glycol Chitosan-Gold Nanoparticles
Patent №
US 9,717,807
Granted
2017-08-01
Filed 2014
Owner
DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
+2 more
Lab
—
AI components
1
vision
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
14402214
The present invention relates to a CT contrast agent for detecting a thrombus, comprising fibrin-targeted peptide sequence-conjugated glycol chitosan-gold nanoparticles. The CT contrast agent for detecting a thrombus according to an embodiment of the present invention may allow rapid and repeated acquisition of CT image information related to the size and location of a thrombus in cardio-cerebral vascular thrombosis, and also enables the imaging monitoring of cerebral thrombus.
AI classification
Ownership
DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
assignment · 342200531
KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY
assignment · 342200620
SNU R&DB FOUNDATION
assignment · 342200679
Assignors
KIM, DONG EOG, KIM, JEONG YEON
On an employer assignment, the assignors are typically the inventors.